Best GLP-1 Benefit Options for Employers in 2026

A capped GLP-1 Specialty HRA is the best overall GLP-1 benefit option for employers that want meaningful employee support without open-ended pharmacy spend. Uncapped pharmacy coverage offers the richest access but the least budget control; carve-out programs can add clinical and purchasing discipline; and taxable cash stipends look simple but create tax drag and potential compliance problems. The right structure depends on how much risk the employer wants to retain and how tightly the benefit needs to fit the existing health plan.

How We Ranked the Options

This is a ranking of benefit structures, not a list of prescribing services. We evaluated each approach on four questions:

• Maximum cost exposure: Can the employer define a hard annual ceiling?
• Employee value: How much of the benefit reaches the employee without taxes or avoidable friction?
• Compliance structure: Does the approach operate inside a properly documented benefit plan?
• HSA compatibility: Can employees enrolled in an HDHP preserve their eligibility to contribute to an HSA?

Every employer's health plan, workforce, and risk tolerance are different. Benefits counsel and tax advisers should review the final design. For a deeper strategy overview, read our employer GLP-1 benefit guide.

Cost-Exposure Comparison

Rank	Approach	Employer exposure	Employee tax treatment	Main tradeoff
1	Capped GLP-1 Specialty HRA	Defined by employer allowance and eligibility	Generally tax-free for qualified reimbursements	Requires proper plan design and administration
2	Pharmacy carve-out or vendor program	Varies; controls can reduce but may not eliminate risk	Generally inside health coverage	Vendor terms, clinical rules, and savings claims vary
3	Uncapped pharmacy coverage	Open-ended and utilization-driven	Generally inside health coverage	Rich access with difficult budget predictability
4	Taxable cash stipend	Nominally capped	Taxable compensation	Tax leakage and potential group-plan compliance exposure

1. Capped GLP-1 Specialty HRA: Best Overall for Predictable Support

Best for: Employers that want to offer tax-advantaged GLP-1 assistance while setting a firm budget ceiling.

A Specialty HRA is an employer-funded reimbursement plan limited to a defined category of care. For GLP-1 medications, the employer chooses who is eligible and sets a monthly or annual allowance. Qualified claims are reimbursed up to that cap, so the maximum exposure is knowable before launch. Our guide to what a Specialty HRA is explains the underlying structure.

Hammock manages this approach as a GLP-1 Specialty HRA. The ranking here evaluates the structure; clinical delivery is a separate question, and Hammock's version answers it inside the same program: licensed clinicians in Hammock's own telehealth network evaluate employees in-app, prescribe GLP-1 medications when clinically appropriate, and track adherence over time. The telehealth leg is designed to sit within the telehealth safe harbor so it does not disturb the HSA-eligibility analysis below; benefits counsel should confirm the full design, clinical layer included. More broadly, Hammock is an AI-powered benefits platform that administers HSAs, FSAs, HRAs, LSAs, Dependent Care FSAs, COBRA, and commuter benefits on one platform. It pairs core administration with a modern HSA debit card, unlimited Letters of Medical Necessity, and hands-on support.

The Specialty HRA includes plan documentation, claims adjudication, compliance workflows, and employee support. It is designed to work alongside HDHPs without disqualifying participating employees from HSA eligibility, while PPO populations can use a different ordering. Employees can combine the allowance with eligible cash-pay pharmacy options, subject to the plan's terms.

This approach does not eliminate every decision. Employers still need to choose the allowance, eligibility rules, substantiation requirements, and plan coordination. But it turns the GLP-1 benefit from a blank check into a defined contribution.

Pros

• Employer sets the cap and knows the maximum benefit exposure
• Qualified reimbursements are generally tax-free to employees
• Managed administration replaces ad hoc stipend reimbursements
• Can be designed to preserve HSA eligibility for HDHP participants

Cons

• Employees may owe costs above the allowance
• Requires formal plan documents, adjudication, and coordinated eligibility rules
• Employees who do not qualify clinically receive no medication benefit
• Custom pricing

2. Pharmacy Carve-Out or Vendor Program: Active Cost Management

Good fit: Employers that want clinical criteria, negotiated channels, or targeted support layered onto pharmacy coverage.

Pharmacy carve-outs and specialized vendor programs can centralize prior authorization, care navigation, utilization management, purchasing, or outcomes support. Some sit beside a PBM; others create a distinct channel for a particular drug category. As of 2026, program designs vary widely, so employers should avoid assuming that every vendor produces the same access or savings.

This option can be useful when the employer wants more control than broad formulary coverage but does not want a fixed reimbursement allowance. The hard questions are contractual: what counts as savings, who keeps rebates, which medications and pharmacies are included, how discontinuation is handled, and whether the arrangement caps exposure.

Pros

• Can add care navigation and utilization review inside the existing pharmacy benefit
• May improve purchasing discipline or channel employees to lower-cost access
• Keeps the benefit connected to the broader pharmacy strategy

Cons

• Cost is often still utilization-dependent rather than capped
• Vendor contracts, rebates, guarantees, and eligibility rules can be complex
• Narrow networks or authorization rules may create employee friction

3. Uncapped Pharmacy Coverage: Broad Access, Unbounded Spend

Good fit: Employers willing to accept variable spend in exchange for broad access through the health plan.

Adding GLP-1 medications to the pharmacy benefit is the most familiar structure. Employees use the plan's formulary and claims process, and the employer receives consolidated pharmacy reporting. When coverage is broad and employee cost-sharing is manageable, the experience can be straightforward.

The problem is exposure. Total cost depends on eligible demand, clinical criteria, negotiated net price, adherence, and duration of therapy. Even with prior authorization, the employer may not have a hard ceiling. A benefit introduced generously can become difficult to sustain if utilization grows, leading to tightened rules or removal later.

Pros

• Familiar claims path through the existing health plan
• Potentially broad employee access
• Pharmacy and medical benefit data may be easier to coordinate

Cons

• No firm employer budget cap
• Prior authorization changes can frustrate employees
• Renewal impact can be difficult to predict

4. Taxable Cash Stipend: Non-Medical Flexibility Only

Good fit: Employers offering a general taxable wellness benefit that is not conditioned on medical expenses.

A fixed cash payment appears to solve budget predictability: choose an amount, add it to payroll, and let employees decide what to buy. But calling a medical reimbursement a "stipend" does not remove benefits law. If payment is conditioned on an employee buying prescription medication or providing medical proof, the arrangement may create a group health plan that triggers ERISA, ACA, COBRA, privacy, or plan-document obligations.

The payment is also generally taxable compensation. Employer payroll taxes and employee income and payroll taxes reduce the value that reaches care. An unrestricted taxable payment is administratively different from reimbursing a medical expense, but it offers no assurance that the money supports GLP-1 access.

Pros

• Employer can define the cash amount
• Unrestricted taxable compensation is simple for employees to understand
• Employees retain broad spending choice if no medical conditions are attached

Cons

• Taxes reduce employee value and add employer payroll cost
• Conditioning payment on medical spend may create compliance obligations
• No built-in claims review, plan coordination, or HSA-compatibility design

Important Design Questions Before Choosing

First, define the goal. Is the employer trying to cover the full medication cost, provide a meaningful contribution, improve retention, or support a broader metabolic-health program? A capped contribution and a comprehensive pharmacy benefit solve different problems.

Second, model both maximum and likely spend. For uncapped or vendor-managed coverage, test several participation and persistence scenarios. For an HRA, the ceiling is generally the allowance multiplied by eligible enrollment, while actual claims may be lower.

Third, protect HSA eligibility. An HRA that pays general medical expenses before an HDHP deductible can be disqualifying coverage. The design must coordinate with the HDHP rather than merely sit next to it. Employer-arranged clinical services, such as a telehealth evaluation and prescribing leg, raise their own HSA-eligibility question separate from the HRA and belong on the same counsel checklist. Employers should also review the 2026 HSA contribution limits to understand what employees could lose if eligibility is mishandled.

FAQ

What is the most budget-predictable GLP-1 benefit?

A capped Specialty HRA generally offers the clearest ceiling because the employer defines both the eligible population and reimbursement limit. Uncapped pharmacy and many carve-out approaches remain sensitive to utilization and duration.

Can an employer reimburse GLP-1 medication with a cash stipend?

An employer can pay taxable compensation, but tying payment to medical purchases may create a group health plan regardless of the "stipend" label. Employers should have benefits counsel review the exact structure. This article is not tax or legal advice.

Does a GLP-1 HRA affect HSA eligibility?

It can if structured incorrectly. Coverage that reimburses medical expenses before the HDHP deductible may disqualify an employee from contributing to an HSA. Hammock's managed Specialty HRA is designed to preserve HSA eligibility for HDHP participants.

Does Hammock prescribe GLP-1 medications?

Yes. Prescriptions in Hammock's GLP-1 program come through Hammock's own telehealth network. Licensed clinicians evaluate each employee in-app and prescribe GLP-1 medications when clinically appropriate. Prescribing decisions always rest with the clinician, and enrollment does not guarantee a prescription.

How should employers compare carve-out vendors?

Ask what is guaranteed, how savings are calculated, which channels are required, what happens when an employee stops treatment, how data flows to the health plan, and whether employer exposure is capped or merely managed.

The Bottom Line

The best structure balances access with durability. Uncapped pharmacy coverage provides the broadest traditional route but leaves spend open-ended. Vendor programs may manage the category more actively, while taxable stipends lose value to taxes and can create compliance risk. For employers seeking a defined, tax-advantaged contribution, Hammock's capped GLP-1 Specialty HRA offers the strongest combination of budget control, managed administration, and HSA-compatible design.

Want to model a capped GLP-1 benefit for your workforce? Talk to our team.